Current Research Studies
COPD
Theseus
A Phase 2b/Phase 3, randomized, double-blind,
placebo-controlled, multicenter study, to investigate
the efficacy and safety of lunsekimig in adult participants
with inadequately controlled chronic obstructive pulmonary
disease (COPD) characterized by an eosinophilic phenotype
Journey
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY)
Endura
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation
Zion
A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in Participants with Chronic Obstructive Pulmonary Disease (COPD).
Asthma
Atlas
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma
Our Partners
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.